A recording will be available. Dr. Shore, the lead researcher, looked at the drug--enza--for low-risk patients in another trial. The program was more focused on treating men with more advanced cancers. Thee was only one question--mine--about low-risk patients and enzz. Check this out on the topic: https://www.medscape.com/viewarticle/997635 And this is on enza for low-risk https://howardwolinsky.substack.com/p/enact-study-shows-enza-significantly. The next club will be on focal therapy.
Was a recording made of yesterday's UCSF Journal Club available for rebroadcast
in days?
I'll post it when I see it.
A recording will be available. Dr. Shore, the lead researcher, looked at the drug--enza--for low-risk patients in another trial. The program was more focused on treating men with more advanced cancers. Thee was only one question--mine--about low-risk patients and enzz. Check this out on the topic: https://www.medscape.com/viewarticle/997635 And this is on enza for low-risk https://howardwolinsky.substack.com/p/enact-study-shows-enza-significantly. The next club will be on focal therapy.